Replies to post #150578 on Biotech Values

[DewDiligence]

As a practical matter, hardly anyone prescribes an ACE+ARB regimen (and even fewer third-party payers reimburse for it). But maybe it’s not such a bad idea for those with hypertension at higher-than-average risk for dementia.